• Verapamil HCl: Novel Insights in Bone Turnover and Osteoporo

  2026-07-03

  Explore the advanced mechanisms of Verapamil HCl as an L-type calcium channel blocker, with special focus on its impact on bone turnover and osteoporosis. This article offers a uniquely deep analysis of TXNIP pathway modulation, bridging cellular, animal, and translational research.

• CA-074 Me: Precision Cathepsin B Inhibitor for Lysosomal Stu

  2026-07-03

  CA-074 Me empowers researchers to dissect lysosomal membrane permeabilization and cell death mechanisms with unmatched selectivity and intracellular potency. Optimized for apoptosis, necroptosis, and inflammation research, this cathepsin B inhibitor delivers reproducible inhibition even in complex cellular assays.

• Thymosin-β4 Promotes Angiogenesis via Notch/NF-κB in Limb Is

  2026-07-02

  Lv et al. (2020) reveal that thymosin-β4 (Tβ4) enhances angiogenesis in a mouse model of critical limb ischemia by modulating Notch and NF-κB signaling pathways. Their work advances understanding of vascular regeneration mechanisms and highlights key molecular targets for therapeutic intervention.

• YC-1 in Translational Oncology: Mechanisms, Strategies, Hori

  2026-07-02

  This article delivers a strategic, mechanistic, and actionable perspective on YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol for translational researchers. By weaving together recent advances in hypoxia signaling, tumor angiogenesis inhibition, and neuroinflammatory mechanisms, it frames the unique potential of YC-1 as provided by APExBIO, highlights protocol insights, and contextualizes new findings—such as the CGRP/SP-Piezo2 axis in neuropathic pain—to chart new research directions.

• Targeting SCAP Factors to Eliminate Senescent Glioblastoma C

  2026-07-01

  This study identifies c-IAP1, c-IAP2, and Bcl-2 as critical survival factors in senescent glioblastoma cells following temozolomide treatment. By inhibiting these factors, the authors demonstrate a synergistic approach to selectively eliminating senescent tumor cells, offering new avenues for enhancing glioblastoma therapy.

• Immunophenotype and Thioguanine Sensitivity in Relapsed Chil

  2026-07-01

  This study systematically evaluated drug resistance profiles in relapsed pediatric acute lymphoblastic leukemia (ALL) by immunophenotype, revealing that T-cell ALL, despite its poorer prognosis, shows increased in vitro sensitivity to thiopurines such as thioguanine. These findings support the rationale for tailored use of thiopurines in relapsed T-cell ALL and inform future precision therapy strategies.

• Applied Strategies with the 3X (DYKDDDDK) Peptide for Protei

  2026-06-30

  The 3X (DYKDDDDK) Peptide enables ultra-sensitive detection and robust affinity purification workflows for recombinant proteins, minimizing interference with structure or function. Discover how its trimeric design elevates immunodetection, structural biology, and metal-dependent assays—plus actionable protocol enhancements and troubleshooting tips.

• Nebivolol Hydrochloride: Precision β1-Adrenoceptor Antagonis

  2026-06-30

  Nebivolol hydrochloride delivers unmatched selectivity for β1-adrenoceptor signaling research, providing clear separation from mTOR pathway modulation. This guide details experimental protocols, troubleshooting, and advanced applications that maximize reproducibility in cardiovascular pharmacology, hypertension, and heart failure studies.

• WSP-5 for Live-Cell Imaging of Hydrogen Sulfide Dynamics

  2026-06-29

  WSP-5 (Washington State Probe-5) provides sensitive, real-time detection of hydrogen sulfide (H2S), enabling rapid and reproducible visualization of H2S fluctuations in live-cell and disease models. Its superior activation kinetics empower advanced studies in cardiometabolic dysfunction and cancer biology, supporting both basic research and drug discovery.

• Genetic Toxicology of Glutaraldehyde: Insights from the HGPR

  2026-06-29

  This article reviews the comprehensive genetic toxicology assessment of glutaraldehyde, focusing on both in vitro and in vivo assay outcomes. The study's methodical approach, especially regarding the HGPRT locus and related 6-thioguanine resistance endpoints, informs best practices for evaluating mutagenic and clastogenic risks in chemical safety research.

• Pazopanib Hydrochloride: Precision Oncology and In Vitro Dru

  2026-06-28

  Explore the multifaceted role of Pazopanib Hydrochloride in cancer research, with a focus on advanced in vitro drug response metrics and translational assay design. Discover how this multi-target kinase inhibitor empowers more precise evaluation in oncology studies.

• Ertugliflozin (PF-04971729): Optimizing SGLT2 Inhibition Wor

  2026-06-27

  Ertugliflozin (PF-04971729) stands out as a highly selective SGLT2 inhibitor, driving robust results in diabetes mellitus research and emerging neurodegeneration studies. This article delivers hands-on protocol strategies, troubleshooting tips, and data-driven insights to maximize reproducibility and translational value in your lab.

• CA-074 Me: Precision Cathepsin B Inhibition in Lysosomal Ass

  2026-06-26

  CA-074 Me (Cathepsin B inhibitor) delivers unmatched selectivity and cell permeability for dissecting lysosomal enzyme pathways and regulated cell death. This guide translates new mechanistic insights into actionable workflows, troubleshooting, and comparative strategies for inflammation and apoptosis research.

• Verapamil HCl: Intracellular Mechanisms and Experimental Lev

  2026-06-26

  Explore the advanced intracellular actions of Verapamil HCl, a leading L-type calcium channel blocker, in apoptosis and inflammation research. This cornerstone article uniquely dissects its dual role as both a channel modulator and a multidrug resistance modifier, empowering innovative assay designs.

• Gene Expression Profiling Reveals PARP Inhibitor Sensitivity

  2026-06-25

  Borchert et al. identified homologous recombination repair (HRR) defects in malignant pleural mesothelioma (MPM) that predict sensitivity to PARP inhibitors, particularly in BAP1-mutated cell lines. Their findings highlight the potential for gene expression profiling to guide targeted therapy in MPM, and underscore the role of DNA repair pathways in chemoresistance.

16415 records 1/1095 page Next 12345 下5页 Last page